Production Featured Articles

  1. Viruses And Viral Vectors, Are They Different? 10/23/2024

    Learn how effective disinfection solutions can ensure safety in pharmaceutical manufacturing by managing viral contaminants and enhancing patient protection.

  2. Visually Clean And Beyond 10/23/2024

    Implement a robust cleaning and sanitization program to ensure the safety and quality of personal care and cosmetics products while complying with global regulations.

  3. How Is Additive Manufacturing Delivering On Sustainability Goals? 10/22/2024

    One of the key concerns for many biopharmaceutical companies is minimizing environmental impact. Learn about additive manufacturing and the significant advantages it offers to biomanufacturers.

  4. Designing Shelf-Stable, Dry Powder Vaccines To Improve Global Access 10/10/2024

    Spray dry technology is being leveraged to create shelf-stable, dry-powder vaccines to treat and prevent the spread of tuberculosis which could significantly improve our global response to disease.

  5. Leveraging Communal Goals To Build A Sustainable Future For Pharma Manufacturing 10/9/2024

    Rethinking your company’s SOPs to reduce carbon emissions and ensure more sustainable workflows is no easy feat. The key is looking at these initiatives as a crucial, community-driven effort.

  6. Sterility Assurance: The Fundamentals 10/8/2024

    Sterility assurance is a critical aspect of the production of drugs and medical devices. This article covers the fundamentals, including the key components of an effective sterility assurance program.

  7. Expert Voices: Why Aren't QC Labs Fully Automated Yet? 10/4/2024

    Leading automation experts chime in on why QC labs, otherwise ideal for robotics, have been slow to adopt and standardize the technology.

  8. How Digital Twins Are Redefining Biotech Production And Labor 10/1/2024

    Digital Twins are revolutionizing biotechnology by optimizing production processes, enhancing quality control, and changing the workforce. They offer efficiency, predictive maintenance, and compliance benefits.

  9. Innovative Octet® Biolayer Interferometry (BLI) Approach For Non-Disruptive And Fast AAV Capsid Ratio Determination In Complex Biological Matrices 9/27/2024

    Learn about a biosensor that was designed to provide the rapid, real-time, high-throughput measurement of AAV capsid titer in samples throughout the AAV workflow.

  10. EMA Issues Draft Guideline On The Development And Manufacture Of Oligonucleotides 9/26/2024

    The EMA recently issued a draft guidance, Guideline on the Development and Manufacture of Oligonucleotides. It includes requirements and considerations related to conjugation, active substance in solution, and more. The consultation period ends Jan. 31, 2025.